Sorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinoma

Toll like receptor 4 and hepatocellular carcinoma; A systematic review

(2017) Zahra Sepehri et al.   LIFE SCIENCES

Lipopolysaccharide supports maintaining the stemness of CD133+ hepatoma cells through activation of the NF-κB/HIF-1α pathway

(2016) Fo-Bao Lai et al.   CANCER LETTERS

Small ubiquitin-related modifier 1 is involved in hepatocellular carcinoma progression via mediating p65 nuclear translocation

(2016) Jun Liu et al.   Oncotarget

Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma

(2016) Qun Chu et al.   Oncotarget

Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases

(2015) Michael P. Lux et al.   BMC CANCER

Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma

(2015) Wen-Ting Liu et al.   CANCER LETTERS

TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells

(2015) Ang Lin et al.   OncoImmunology

Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice

(2013) Ziyan Wang et al.   HEPATOLOGY

Caspase-1 is a novel target of p63 in tumor suppression

(2013) I Celardo et al.   Cell Death & Disease

Functional Genomic Studies: Insights into the Pathogenesis of Liver Cancer

(2012) Ze-Guang Han   Annual Review of Genomics and Human Genetics

Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide

(2012) Ying-Ying Jing et al.   BMC Medicine

Sorafenib Inhibits Hypoxia-Inducible Factor-1  Synthesis: Implications for Antiangiogenic Activity in Hepatocellular Carcinoma

(2012) L.-p. Liu et al.   CLINICAL CANCER RESEARCH

High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases

(2012) Wei Yan et al.   HEPATOLOGY

Inflammasomes in liver diseases

(2012) Gyongyi Szabo et al.   JOURNAL OF HEPATOLOGY

The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

(2011) Beckley K. Davis et al.   Annual Review of Immunology

Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo

(2011) Yu-Cheng Kuo et al.   BIOMEDICINE & PHARMACOTHERAPY

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

(2010) Elizabeth C. Finger et al.   CANCER AND METASTASIS REVIEWS

Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion

(2010) Wei Ding et al.   HEPATOLOGY

Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4

(2010) B. Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Current Management of Hepatocellular Cancer

(2010) Bernardino Rampone et al.   Current Oncology Reports

EMT, the cytoskeleton, and cancer cell invasion

(2009) Mahmut Yilmaz et al.   CANCER AND METASTASIS REVIEWS

Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β

(2009) Miyako Okamoto et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cytokines as a key component of cancer-related inflammation

(2008) Giovanni Germano et al.   CYTOKINE

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE